Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

HeadHunter extended the acceptance of applications for exchange of receipts for shares

11/17/23 HEAD

Moscow Exchange launched a broker selection service

11/17/23 MOEX

Renaissance Insurance reported for 9 months of 2023

11/17/23 RENI

MKB reported for 9 months of 2023 by IFRS

11/17/23 CBOM

TCS Group will enter the advertising market

11/17/23 T

TRK reported for 9 months of 2023 by IFRS

11/17/23 TORS

Board of Directors of Sovcomflot recommended dividends

11/16/23 FLOT

Shareholders are planning to change NLMK's president

11/16/23 NLMK

Whoosh tested an electric scooter with a computer vision module

11/16/23 WUSH

Walmart reported for 9 months of fiscal year 2024

11/16/23 WMT